Abstract
Correction to: Experimental & Molecular Medicinehttps://doi.org/10.1038/s12276-022-00840-x, published online 02 September 2022 After online publication of this article, the authors noticed an error in the Fig. 5h section. During figure assembly, the image corresponding to the siAXL#1 condition in Fig. 5h was inadvertently replaced with the siScrambled image from Fig. 5e. (Figure presented.) The correct siAXL#1 image was obtained from the same experiment performed under identical conditions. Original data are available upon request. This error does not affect the quantitative analyses, statistical results, or the conclusions of the manuscript. The authors apologize for any inconvenience caused. The original article has been corrected.
| Original language | English |
|---|---|
| Pages (from-to) | 300 |
| Number of pages | 1 |
| Journal | Experimental and Molecular Medicine |
| Volume | 58 |
| Issue number | 1 |
| DOIs |
|
| State | Published - Feb 2026 |
Fingerprint
Dive into the research topics of 'Author Correction: BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity (Experimental & Molecular Medicine, (2022), 54, 9, (1450-1460), 10.1038/s12276-022-00840-x)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver